MGP
BSX icon

Metis Global Partners’s Boston Scientific BSX Stock Holding History

Metis Global Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
44,530
+2,306
+5% +$125K 0.04% 318
2026
Q1 		$2.65M Sell
42,224
-4,648
-10% -$372K 0.07% 237
2025
Q4 		$4.47M Sell
46,872
-19,522
-29% -$1.91M 0.11% 161
2025
Q3 		$6.48M Buy
66,394
+478
+0.7% +$49.5K 0.15% 114
2025
Q2 		$7.08M Sell
65,916
-7,142
-10% -$723K 0.18% 92
2025
Q1 		$7.37M Buy
73,058
+11,106
+18% +$1.12M 0.21% 86
2024
Q4 		$5.53M Buy
61,952
+2,726
+5% +$240K 0.17% 103
2024
Q3 		$4.96M Buy
59,226
+2,248
+4% +$177K 0.15% 116
2024
Q2 		$4.39M Buy
56,978
+498
+0.9% +$36.5K 0.15% 113
2024
Q1 		$3.87M Sell
56,480
-466
-0.8% -$30K 0.14% 126
2023
Q4 		$3.29M Sell
56,946
-4,344
-7% -$232K 0.13% 137
2023
Q3 		$3.24M Buy
61,290
+5,875
+11% +$308K 0.16% 125
2023
Q2 		$3M Buy
55,415
+202
+0.4% +$10.6K 0.16% 123
2023
Q1 		$2.76M Buy
55,213
+14,914
+37% +$703K 0.18% 118
2022
Q4 		$1.86M Buy
40,299
+14,514
+56% +$628K 0.17% 135
2022
Q3 		$1M Buy
25,785
+1,884
+8% +$75.6K 0.16% 150
2022
Q2 		$891K Buy
23,901
+1,380
+6% +$56.2K 0.14% 170
2022
Q1 		$998K Buy
22,521
+10,103
+81% +$438K 0.12% 156
2021
Q4 		$528K Buy
+12,418
New +$522K 0.15% 152

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Metis Global Partners's BSX Position: Q2 2026 in Review

Metis Global Partners increased its Boston Scientific (BSX) stake by 5.5% in Q2 2026, buying an estimated $125K and bringing the position to 44,530 shares worth $1.9M. The position accounts for 0.04% of the portfolio, ranked #318.

Metis Global Partners first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.37M in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Metis Global Partners held 44,530 shares of Boston Scientific worth $1.9M as of Q2 2026.
  • Metis Global Partners bought 2,306 Boston Scientific shares in Q2 2026, an estimated $125K.
  • Boston Scientific made up 0.04% of Metis Global Partners's portfolio in Q2 2026, its #318 holding.
  • Metis Global Partners first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Boston Scientific position peaked at $7.37M in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.